SCHEMBL20439174

SCHEMBL20439174

CN(C)c1noc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
MAOB P27338 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
CYP3A4 P08684 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29940874 0.85 MAOA (0.44) HIF1ACA12CA1CA2LMNA
SCHEMBL28906151 0.85 MAOA (0.44) HIF1ACA12CA1CA2LMNA
SCHEMBL20909684 0.75 CHRNA7 (0.39) HIF1ALMNAMAOBESR1ESR2
SCHEMBL19633722 0.75 LATS1 (0.42) HIF1ALMNACYP3A4SMN1; SMN2ALDH1A1
SCHEMBL6990363 0.73 FAAH (0.40) HIF1ACA12CA1CA2LMNA
SCHEMBL7379181 0.73 CYP1A2 (0.35) HIF1ALMNAESR1ESR2CYP3A4
SCHEMBL14427259 0.72 HIF1A (0.40) HIF1ALMNASMN1; SMN2GAA
SCHEMBL30667359 0.71 EPHX2 (0.44) HIF1AESR1ESR2EPHX2KCNA5
SCHEMBL12331 0.71 LMNA (0.44) HIF1ACA12CA1CA2LMNA
SCHEMBL20884969 0.71 TBK1 (0.34) LMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10383881-B2 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same Frequency Therapeutics, Inc. (US) 2019-08-20 US disclosed
US-20180214458-A1 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214458-A1 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME DCX, MKI67, MCL1 HIF1A 223/4885CA12 4282/4885CA1 3163/4885
US-10383881-B2 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same DCX, MKI67, MCL1 HIF1A 223/4885CA12 4282/4885CA1 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.